Par Drugs and Chemicals Limited (NSE:PAR)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Manufacturing of API	1.04B	1.01B	956.40M	957.49M	750.74M
Manufacturing of API Growth	2.66%	5.58%	-0.11%	27.54%	23.58%
Total	1.04B	1.01B	956.40M	957.49M	750.74M
Total Growth	2.66%	5.58%	-0.11%	27.54%	23.58%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	752.29M	718.17M	751.19M	562.73M
India Growth	4.75%	-4.40%	33.49%	12.16%
Unallocated	4.27M	5.34M	6.54M	8.74M
Unallocated Growth	-19.95%	-18.34%	-25.22%	-0.07%
Export	253.17M	232.89M	199.76M	179.27M
Export Growth	8.70%	16.59%	11.43%	84.71%
Total	1.01B	956.40M	957.49M	750.74M
Total Growth	5.58%	-0.11%	27.54%	23.58%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 11, 2026

Data Sources Report a data error